Takeda Pharmaceuticals USA, Inc.
GPTKB entity
Statements (49)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Shire_plc
Acquired Ariad Pharmaceuticals Acquired Envoy Therapeutics Acquired Frazier Healthcare Partners Acquired Nimbus Therapeutics Acquired Ti Genix |
| gptkbp:awards |
Recognized for workplace culture
Received awards for innovation Awarded for sustainability efforts Received accolades for diversity and inclusion |
| gptkbp:ceo |
gptkb:Christophe_Weber
|
| gptkbp:clinical_trial |
Conducts numerous clinical trials
Involvement in global health initiatives Focus on innovative therapies Collaboration with patient advocacy groups |
| gptkbp:community_engagement |
Supports local communities
Involved in disaster relief efforts Promotes STEM education initiatives Engages in volunteer programs Supports health education programs Provides scholarships and grants |
| gptkbp:employees |
Approximately 50,000
|
| gptkbp:focus_area |
gptkb:healthcare_organization
Gastroenterology Neuroscience Rare diseases |
| gptkbp:founded |
1781
|
| gptkbp:global_presence |
Operates in over 70 countries
|
| gptkbp:headquarters |
gptkb:Deerfield,_Illinois
|
| https://www.w3.org/2000/01/rdf-schema#label |
Takeda Pharmaceuticals USA, Inc.
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:parent_company |
gptkb:Takeda_Pharmaceutical_Company_Limited
|
| gptkbp:partnership |
Various academic institutions
Partnership with Microsoft Partnership with Google Cloud Partnership with various biotech firms |
| gptkbp:products |
Prescription drugs
|
| gptkbp:research_and_development |
Invests heavily in R& D
|
| gptkbp:research_areas |
Immunology
Hematology Metabolic disorders Cardiovascular |
| gptkbp:revenue |
$17.3 billion (2020)
|
| gptkbp:subsidiary |
gptkb:Takeda_Pharmaceuticals_North_America,_Inc.
|
| gptkbp:sustainability_initiatives |
Focus on environmental sustainability
|
| gptkbp:website |
www.takeda.com
|
| gptkbp:bfsParent |
gptkb:Takeda_Pharmaceutical_Company
|
| gptkbp:bfsLayer |
3
|